Amylyx Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMLX and other ETFs, options, and stocks.

About AMLX

Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada.

CEO

Joshua B. Cohen

CEOJoshua B. Cohen

Employees

123

Employees123

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2013

Founded2013

Employees

123

Employees123

AMLX Key Statistics

Market cap

448.77M

Market cap448.77M

Price-Earnings ratio

-1.14

Price-Earnings ratio-1.14

Dividend yield

—

Dividend yield—

Average volume

916.52K

Average volume916.52K

High today

$5.24

High today$5.24

Low today

$4.90

Low today$4.90

Open price

$5.07

Open price$5.07

Volume

1.08M

Volume1.08M

52 Week high

$7.27

52 Week high$7.27

52 Week low

$1.58

52 Week low$1.58

Analyst ratings

67%

of 6 ratings

Buy

66.7%

Hold

33.3%

Sell